AI Summary
This is a limited competition grant opportunity under the Clinical and Translational Science Award (CTSA) Program, specifically for the Collaborative and Innovative Acceleration Award. It involves a UG3/UH3 Clinical Trial Optional funding mechanism, and applications are due by October 19, 2027.